​

HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCA Stock Forecast

HCA Healthcare (HCA) stock forecast, based on 46 Wall Street analysts, predicts a 12-month average price target of $409.00, with a high of $416.00 and a low of $401.00. This represents a 3.71% increase from the last price of $394.36.

$250 $290 $330 $370 $410 $450 High: $416 Avg: $409 Low: $401 Last Closed Price: $394.36

HCA Stock Rating

HCA Healthcare stock's rating consensus is Buy, based on 46 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 31 Buy (67.39%), 14 Hold (30.43%), 1 Sell (2.17%), and 0 Strong Sell (0.00%).

Buy
Total 46 1 14 31 Strong Sell Sell Hold Buy Strong Buy

HCA Price Target Upside V Benchmarks

TypeNameUpside
StockHCA Healthcare3.71%
SectorHealthcare Stocks 13.55%
IndustryMedical Care Facilities Stocks14.92%

Price Target Trends

1M3M12M
# Anlaysts-19
Avg Price Target-$401.00$417.56
Last Closing Price$394.36$394.36$394.36
Upside/Downside-1.68%5.88%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2521210-125
Aug, 2521211--25
Jul, 252139-125
Jun, 252139-125
May, 2521391-25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2025Ben HendrixRBC Capital$401.00$334.2919.96%1.68%
Jun 09, 2025Craig HettenbachMorgan Stanley$410.00$373.019.92%3.97%
Jun 02, 2025Andrew MokBarclays$416.00$382.168.85%5.49%
Jan 07, 2025Matthew GillmorKeyBanc$370.00$308.2120.05%-6.18%
Oct 28, 2024Michael WiederhornOppenheimer$400.00$359.0711.40%1.43%
Oct 28, 2024Matthew GillmorKeyBanc$420.00$359.0716.97%6.50%
Oct 28, 2024Ann HynesMizuho Securities$425.00$359.1618.33%7.77%
Oct 10, 2024Matthew GillmorKeyBanc$475.00$387.2522.66%20.45%
Oct 01, 2024Pito ChickeringDeutsche Bank$441.00$406.018.62%11.83%
Aug 19, 2024David MacDonaldTruist Financial$430.00$373.7715.04%9.04%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2025RBC CapitalOutperformOutperformhold
Jul 28, 2025Wolfe ResearchPeer Performdowngrade
Jun 23, 2025RBC CapitalOutperformOutperformhold
Jun 02, 2025BarclaysOverweightOverweighthold
May 29, 2025Wells FargoEqual-WeightEqual-Weightupgrade
Jan 07, 2025KeyBancOverweightOverweighthold
Oct 28, 2024OppenheimerOutperformOutperformhold
Oct 28, 2024KeyBancOverweightOverweighthold
Oct 16, 2024Cowen & Co.BuyBuyhold
Oct 10, 2024KeyBancOverweightinitialise

Financial Forecast

EPS Forecast

$0 $7 $14 $21 $28 $35 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$11.10$21.51$19.44$19.24$0.08---
Avg Forecast$11.07$17.85$17.01$18.20$21.94$24.84$27.96$31.30
High Forecast$11.27$18.16$17.35$18.50$22.15$25.34$29.09$32.50
Low Forecast$10.95$17.65$16.82$18.04$21.82$24.06$27.03$30.19
Surprise %0.27%20.50%14.29%5.71%-99.64%---

Revenue Forecast

$50B $57B $64B $71B $78B $85B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$51.53B$58.75B$60.23B$64.97B$70.60B---
Avg Forecast$51.22B$59.02B$60.35B$64.15B$70.57B$74.57B$78.43B$82.55B
High Forecast$51.92B$59.82B$61.26B$64.42B$70.75B$75.20B$79.95B$82.68B
Low Forecast$50.80B$58.53B$59.82B$63.95B$70.43B$73.83B$77.42B$82.43B
Surprise %0.61%-0.46%-0.19%1.27%0.05%---

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$3.75B$6.96B$5.64B$5.24B$21.96M---
Avg Forecast$12.64B$5.84B$6.56B$5.24B$5.76B$6.47B$7.35B$8.21B
High Forecast$15.17B$7.01B$7.87B$6.29B$5.80B$6.63B$7.61B$8.51B
Low Forecast$10.11B$4.68B$5.25B$4.19B$5.71B$6.30B$7.08B$7.90B
Surprise %-70.30%19.01%-14.00%--99.62%---

HCA Forecast FAQ

Is HCA Healthcare stock a buy?

HCA Healthcare stock has a consensus rating of Buy, based on 46 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 31 Buy, 14 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that HCA Healthcare is a favorable investment for most analysts.

What is HCA Healthcare's price target?

HCA Healthcare's price target, set by 46 Wall Street analysts, averages $409 over the next 12 months. The price target range spans from $401 at the low end to $416 at the high end, suggesting a potential 3.71% change from the previous closing price of $394.36.

How does HCA Healthcare stock forecast compare to its benchmarks?

HCA Healthcare's stock forecast shows a 3.71% upside, underperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the medical care facilities stocks industry (14.92%).

What is the breakdown of analyst ratings for HCA Healthcare over the past three months?

  • September 2025: 8.00% Strong Buy, 48.00% Buy, 40.00% Hold, 0% Sell, 4.00% Strong Sell.
  • August 2025: 8.00% Strong Buy, 48.00% Buy, 44.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 8.00% Strong Buy, 52.00% Buy, 36.00% Hold, 0% Sell, 4.00% Strong Sell.

What is HCA Healthcare’s EPS forecast?

HCA Healthcare's average annual EPS forecast for its fiscal year ending in December 2025 is $24.84, marking a 30950.00% increase from the reported $0.08 in 2024. Estimates for the following years are $27.96 in 2026, and $31.3 in 2027.

What is HCA Healthcare’s revenue forecast?

HCA Healthcare's average annual revenue forecast for its fiscal year ending in December 2025 is $74.57B, reflecting a 5.61% increase from the reported $70.6B in 2024. The forecast for 2026 is $78.43B, and $82.55B for 2027.

What is HCA Healthcare’s net income forecast?

HCA Healthcare's net income forecast for the fiscal year ending in December 2025 stands at $6.47B, representing an 29342.21% increase from the reported $21.96M in 2024. Projections indicate $7.35B in 2026, and $8.21B in 2027.